Skip to content

Author

Gu-Quan Chen

We have 1 of 2 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Machine learning-based identification of hub genes and prognostic biomarkers in prostate cancer

EZH2, CDK1, and AURKA constitute an internally validated prognostic risk signature in PCa that links cell cycle dysregulation to an immunosuppressive tumor microenvironment and provides clinically actionable risk stratification and highlights candidate therapeutic targets in prostate cancer.

Gu-Quan Chen, Jie-Feng Zhang, Lin-Fu Zhao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.